Article
Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21 <sup>WAF1/CIP1</sup>
6 Jun 2000
Abstract excerpt
Angiogenesis has been demonstrated to be essential for tumor growth and metastasis, and inhibition of angiogenesis is emerging as a promising strategy for treating cancer. Among the most potent inhibitors of angiogenesis is the fumagillin family of natural products. An analog of fumagillin, known as TNP-470 or AGM-1470, has been undergoing clinical trials for treating a variety of cancers. TNP-470 has been shown...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
